Impact of Weight Loss on the Severity of Albuminuria in Obese Diabetic Patients Undergoing Laparoscopic Sleeve Gastrectomy and One-Anastomosis Gastric Bypass
Overview
Authors
Affiliations
Aim: To examine the effect of weight-loss induced bariatric procedures on albuminuria levels among diabetic patients suffering from obesity.
Methods: Adults patients who suffer from morbid obesity and type 2 diabetes mellitus (T2DM) were included in a prospective cohort study. Subjects were scheduled to undergo laparoscopic sleeve gastrectomy (LSG) or one-anastomosis gastric bypass (OAGB). The albumin-to-creatinine ratio (ACR) was adopted to assess the degree of albuminuria. Microalbuminuria was determined as a ratio of >2.5-30 mg/mmol and >3.5-30 mg/mmol for males and females, respectively, while macroalbuminuria was diagnosed when the ACR exceeded >30 mg/mmol.
Results: The mean uACR decreased significantly from 20.95±16.89 to 9.92±12.69mg/mmol in LSG cohort (p <0.001), and from 19.52±16.65 to 9.34±11.77mg/mmol in the OAGB cohort, with no statistically considerable differences between both cohorts at the end of follow-up (p = 0.78). Twelve months after the procedures, the percentages of cases with microalbuminuria decreased significantly to 23.8% and 23.9%, respectively (p < 0.001); likewise, the percentages of cases with macroalbuminuria significantly decreased to 7.9% and 7.5% in the LSG and OAGB groups, respectively (p < 0.001). There were no statistically considerable differences between LSG and OAGB regarding the percentages of patients with micro or macroalbuminuria at the end of follow-up. Besides, there were no significant associations between the degree of weight loss and improvement (p = 0.959) or remission (p = 0.73) of microalbuminuria.
Conclusion: Bariatric surgery significantly reduced the severity of albuminuria 1-year after the procedure, with no preference for one procedure over the other.
The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus Remission: A Systematic Review.
Mohamed A, Aljabal H, Alalawi A, Al-Nooh N Cureus. 2024; 16(11):e74755.
PMID: 39735002 PMC: 11682853. DOI: 10.7759/cureus.74755.
Einafshar N, Esparham A, Moghani M, Radboy M, Ghamari M, Zandbaf T Obes Surg. 2024; 35(1):329-340.
PMID: 39656373 DOI: 10.1007/s11695-024-07612-8.
Garcia de Lucas M, Caballero I, Fernandez-Garcia J, Dominguez-Rodriguez M, Moreno-Moreno P, Jimenez-Millan A Front Endocrinol (Lausanne). 2023; 14:1240279.
PMID: 37955013 PMC: 10634592. DOI: 10.3389/fendo.2023.1240279.